Dr. Garg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
105 Hickory Ct
Danville, CA 94506Phone+1 847-347-6579
Education & Training
- Kaiser Permanente Northern California (Oakland)Residency, Internal Medicine, 2008 - 2011
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2008
Certifications & Licensure
- CA State Medical License 2010 - 2025
- NY State Medical License 2011 - 2015
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Time-varying brentuximab vedotin pharmacokinetics and weight-based dosing in paediatric patients despite lower exposure in those aged 2 to <6 and 6-11 years.Daping Zhang, Zufei Zhang, Anthony Lee, Keenan Fenton, Shweta Jain
British Journal of Clinical Pharmacology. 2024-09-01 - 9 citationsClinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors.Mei Tang, Amit Garg, Peter L Bonate, Jonathan E Rosenberg, Maria Matsangou
Clinical Pharmacokinetics. 2024-04-01 - 31 citationsPopulation pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancerColby S. Shemesh, Pascal Chanu, Kris M. Jamsen, Russ Wada, Gianluca Rossato
Journal for Immunotherapy of Cancer. 2019-11-21
Press Mentions
- Optimizing Outcomes for Patients with Metastatic Prostate Cancer: Insights from South East Asia Expert PanelFebruary 23rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: